Ledger.Open graph →
SEC Form D · filed April 5, 2018

PIONYR IMMUNOTHERAPEUTICS, INC

Offering
$7.0M
Sold
$7.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Carol F. Gallagher · San Francisco, CADirectorJoshua F. Resnick, M.D · San Francisco, CADirectorLeon F. Chen, Ph.D · San Francisco, CADirectorMichael F. Powell · San Francisco, CADirectorSteven P. James · San Francisco, CAExec · Director · PromoterMatthew F. Krummel, Ph.D · San Francisco, CADirectorIsaac Kim · New York, NYDirectorKevin Gasvoda · Stamford, CTDirectorBetsy Atkins · Coral Gables, FLDirectorDan Sparks · Stamford, CTDirectorDaniel Sparks · Stamford, CTDirectorJustin Mahoney · Stamford, CTExec · Director · PromoterMark Babbe · St Peter Port, Y7DirectorClayton J. White · Glen Cove, NYDirectorLaverne J. Poindexter · Glen Cove, NYDirectorJonathan J. Globerman · Glen Cove, NYDirectorAnthony J. Rozier · Glen Cove, NYDirectorJonathan J. Loutzenhiser · Glen Cove, NYExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗